KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $33.65M | $28.52M | $27.90M | $23.49M | $24.18M | $23.16M | $17.35M | $12.29M |
| Cost of Revenue | $12.31M | $11.81M | $12.53M | $9.72M | $9.24M | $8.31M | $6.54M | $4.72M |
| Gross Profit | $21.33M | $16.71M | $15.37M | $13.77M | $14.94M | $14.85M | $10.81M | $7.57M |
| Gross Margin | 63.40% | 58.59% | 55.09% | 58.62% | 61.78% | 64.13% | 62.29% | 61.57% |
| Operating Expenses | $27.78M | $26.98M | $26.15M | $20.80M | $16.19M | $14.27M | $9.65M | $8.31M |
| Operating Income | $-6.45M | $-10.27M | $-10.78M | $-7.03M | $-1.25M | $585.68K | $1.16M | $-736.25K |
| Operating Margin | -19.16% | -36.01% | -38.65% | -29.93% | -5.19% | 2.53% | 6.71% | -5.99% |
| Net Income | $-6.07M | $-13.74M | $-8.66M | $-4.56M | $-1.21M | $564.35K | $910.57K | $-535.00K |
| Net Margin | -18.03% | -48.18% | -31.05% | -19.42% | -5.01% | 2.44% | 5.25% | -4.35% |
| EPS (Basic) | $-0.13 | $-0.30 | $-0.19 | $-0.10 | $-0.03 | $0.01 | $0.02 | $-0.01 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |